Amanote Research
Register
Sign In
Utilizing TH9 Cells as a Novel Therapeutic Strategy for Malignancies
OncoImmunology
- United States
doi 10.4161/onci.23084
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Allergy
Immunology
Date
March 1, 2013
Authors
Yong Lu
Qing Yi
Publisher
Informa UK Limited
Related search
Targeting the Metabolism of Leukemia Stem Cells as a Novel Therapeutic Strategy
Drugs in Context
Molecular Medicine
Pharmacology
Geroprotectors as a Novel Therapeutic Strategy for COPD, an Accelerating Aging Disease
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
Substrate-Selective COX-2 Inhibition as a Novel Strategy for Therapeutic Endocannabinoid Augmentation
Trends in Pharmacological Sciences
Toxicology
Pharmacology
Regeneration of the Endothelium as a Novel Therapeutic Strategy for Acute Lung Injury
Journal of Clinical Investigation
Medicine
Targeting Midbodies in Ovarian Cancer Stem Cells as a Therapeutic Strategy
A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease
Frontiers in Immunology
Allergy
Immunology
Probiotics for Management of Periodontal Disease: A Novel Therapeutic Strategy?
IOSR Journal of Pharmacy (IOSRPHR)
EZH2 as a Therapeutic Target for Multiple Myeloma and Other Haematological Malignancies
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
Targeting BCL-2 as a Therapeutic Strategy for Primary P210BCR-Abl1-Positive B-All Cells
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology